|Slideshows|June 21, 2021

Prime Day Deals for Mental Health

These deals can help boost you and your patients’ mental health.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Psychiatry on Trial: Are Psychiatrists Responsible for Their Patients’ Criminal Behavior?

ByFernando Espí Forcén, MD, PhD,Susan Hatters Friedman, MD, MSt, DFAPA

August 27th 2026

Digital Amnesia and Why Print Should Be Prized

ByRonald W. Pies, MD

August 21st 2026

What Designing AI Taught Me About Why Psychiatrists Ignore It

ByCynthia Sin Nga Lam, MBBS, MRCPsych

July 28th 2026

Endangered Education: Psychiatric Professional Degrees Under Attack

BySara Sethness, DNP, RN, PMHNP-BC,Lee Moore, DNP, MEd, CRNP-PMH, PMHNP-BC, CNE

June 2nd 2026

Psychiatry Does Not Need a Softer DSM. It Needs a Smarter One.

ByGarrett Rossi, MD

April 30th 2026

Latest CME

In-Person Event

Jersey City Psychiatry

October 2-3, 2026

Register now!

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Gus Alva, MD, DFAPA; Erin Crown, MHS, PA-C

Prime Day Deals for Mental Health

Related Content

Psychiatry on Trial: Are Psychiatrists Responsible for Their Patients’ Criminal Behavior?

Digital Amnesia and Why Print Should Be Prized

What Designing AI Taught Me About Why Psychiatrists Ignore It

Endangered Education: Psychiatric Professional Degrees Under Attack

Psychiatry Does Not Need a Softer DSM. It Needs a Smarter One.

Latest CME

Jersey City Psychiatry

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Cases and Conversations™: Optimizing Administration of Treatment for Patients with Schizophrenia

Trending on Psychiatric Times

The Postmodern Worldview and Contemporary Psychiatry

New Phase 2 Clinical Trial Initiating in 2027: Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder

New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial: The Power of Another COMP360 Dose

Disaster Psychiatry: Lessons From 9/11 and COVID-19

Choosing Sexual Function-Sparing Medications